LOMBARDO, ANGELO LEONE
 Distribuzione geografica
Continente #
NA - Nord America 356
EU - Europa 291
AS - Asia 89
SA - Sud America 1
Totale 737
Nazione #
US - Stati Uniti d'America 355
SE - Svezia 180
RU - Federazione Russa 48
CN - Cina 42
SG - Singapore 38
IT - Italia 37
DE - Germania 7
FI - Finlandia 7
IE - Irlanda 7
JP - Giappone 4
IN - India 3
ES - Italia 2
MK - Macedonia 2
AR - Argentina 1
CA - Canada 1
GB - Regno Unito 1
HK - Hong Kong 1
IQ - Iraq 1
Totale 737
Città #
Ashburn 105
New York 50
Lawrence 46
Princeton 46
Shanghai 34
Singapore 25
Milan 23
Boardman 21
Washington 17
Moscow 13
Dublin 7
Helsinki 7
Monza 3
Zhengzhou 3
Barcelona 2
Bologna 2
Florence 2
Pune 2
Tokyo 2
Baghdad 1
Bitonto 1
Essen 1
Fontana 1
Frankfurt am Main 1
Fremont 1
Genova 1
Görwihl 1
Hanover 1
Hong Kong 1
La Plata 1
Lambton 1
Los Angeles 1
Penarth 1
Rome 1
San Francisco 1
Seattle 1
Sesto San Giovanni 1
Springfield 1
Stockholm 1
Totale 430
Nome #
Genome editing: a tool for research and therapy: Targeted genome editing hits the clinic 48
Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced Ex Vivo and In Vivo Genetic Engineering 31
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 29
A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice 24
Site-specific integration and tailoring of cassette design for sustainable gene transfer 23
An unbiased genome-wide analysis of zinc-finger nuclease specificity 23
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 23
Gene Modification and Three-Dimensional Scaffolds as Novel Tools to Allow the Use of Postnatal Thymic Epithelial Cells for Thymus Regeneration Approaches 21
CRISPR/CAS9-BASED GENOME EDITING TO MODEL THE ANTI-LEUKEMIA IMMUNE RESPONSE AND IDENTIFY ITS MOLECULAR PLAYERS 19
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 19
Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors 19
TCR gene editing results in effective immunotherapy of leukaemia without the development of GvHD 19
Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis 19
Gene therapy for a mucopolysaccharidosis type I murine model with lentiviral-IDUA vector 18
iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF 18
Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice 18
From TCR Gene Transfer to TCR Gene Editing of Central Memory T Lymphocytes for Immunotherapy of Leukemia 18
Limited transgene immune response and long-term expression of human alpha-L-iduronidase in young adult mice with mucopolysaccharidosis type I by liver-directed gene therapy 18
Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice 17
Targeted gene addition in human epithelial stem cells by zinc-finger nuclease-mediated homologous recombination. 17
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease 17
Genomic instability in induced stem cells 17
Genome editing for scalable production of alloantigen-free lentiviral vectors for in vivo gene therapy 17
Targeted genome editing in human repopulating haematopoietic stem cells 16
Loss of transcriptional control over endogenous retroelements during reprogramming to pluripotency 16
TRPML1 links lysosomal calcium to autophagosome biogenesis through the activation of the CaMKKβ/VPS34 pathway 16
Trattamento chirurgico della fibrillazione atriale associata a valvulopatia mitralica. “Maze Procedure” e chirurgia della mitrale. 15
Targeting Integration to Selected Genomic Loci and In Situ Tailoring of Cassette Design Allows Robust Transgene Expression without Perturbing Endogenous Transcription 15
Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery 15
Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency 15
In vitro gene therapy of mucopolysaccharidosis type I by lentiviral vectors 14
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 14
T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency 14
Targeted gene therapy and cell reprogramming in Fanconi anemia 13
Editing Human Lymphocyte Specificity for Safe and Effective Adoptive Immunotherapy of Leukemia 13
IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism 13
Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis 12
Therapeutic gene editing in CD34+ hematopoietic progenitors from Fanconi anemia patients. 12
Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1 12
Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I-/- iPSCs for β cell replacement 11
T Cell Receptor Gene Transfer into Naive and Central Memory Lymphocytes by Lentiviral Vectors for a Safe and Effective Adoptive Immune Therapy of Leukemia 11
The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity 11
Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy 11
Deletion of a pseudogene within a fragile site triggers the oncogenic expression of the mitotic CCSER1 gene 11
Targeted gene correction in osteopetrotic-induced pluripotent stem cells for the generation of functional osteoclasts 10
Use of critical care resources during the first 2 weeks (February 24–March 8, 2020) of the Covid-19 outbreak in Italy 10
Erratum: IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism (Molecular Therapy (2017) 25(10) (2254–2269), (S1525001617303143), (10.1016/j.ymthe.2017.06.029)) 10
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease 9
NY-ESO-1 Single Edited T Cells to Treat Multiple Myeloma without Inducing GvHD 9
In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing 8
Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A 8
Altered Cl− homeostasis hinders forebrain GABAergic interneuron migration in a mouse model of intellectual disability 7
Epigenome-editing strategies to enhance oligodendroglial differentiation from human induced pluripotent stem cells 5
DNA damage contributes to neurotoxic inflammation in Aicardi-Goutières syndrome astrocytes 5
Totale 853
Categoria #
all - tutte 10.228
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.228


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 3 0 0 0 0 0 0 0 0 1 0 0
2020/202111 0 0 0 0 0 8 3 0 0 0 0 0
2021/202232 0 0 0 19 2 0 5 0 3 0 0 3
2022/2023288 99 74 24 3 2 41 8 23 6 2 6 0
2023/2024347 2 15 38 59 41 99 4 21 2 11 15 40
2024/202587 87 0 0 0 0 0 0 0 0 0 0 0
Totale 853